Melinda Taschetta-Millane, Editorial Director
Melinda Taschetta-Millane, Editorial Director
Blog | Melinda Taschetta-Millane, Editorial Director | Coronavirus (COVID-19) | January 21, 2021

We are at the Sunrise of 2021

CNN reported that more than 9 million Americans have received their first dose of the coronavirus vaccine, yet more than 27 million doses have been distributed as of Jan. 13, according to the CDC. Also on Jan. 13, the Trump administration reversed course on its vaccine policy, and instructed states to begin vaccinating all Americans 65 and older, and release the second doses in reserve to make the vaccine more widely administered.

Getty Images

We now are in our third week of the New Year, and our tenth month of social distancing and following various state mandates. Soon, we will have completed a full year of the virtual trade show cycle. Will events — and life — go back to the way it was, or has a “new normal” been created? In this issue’s Parting Thoughts column, Contributing Editor Jef Williams discusses the changes we have experienced that caused a radical shift and set the stage for redefining what is possible moving forward.

Take for instance telehealth. Historically, its adoption has been slow. But when patients and physicians found out how convenient it could be, we saw that original resistance start to shift. As Williams states in his column, “It often takes significant force to exact change.” In December, I had the opportunity to discuss telehealth with Eric Liederman, M.D., M.Ph., director of medical informatics for The Permanente Medical Group, in Kaiser Permanente’s Northern California Region. He shared that a major change in telehealth occurred last March when the Centers for Medicare and Medicaid Services (CMS) issued a waiver that temporarily allowed reimbursement for video and telephone visits on a fee-for-service basis. CMS also issued a statement of forbearance of prosecutions around HIPAA violations, surrounding use of non-commercial grade, non-healthcare grade modalities for video care. 

“So, they basically said we’ll pay you and you can essentially use any means that you want to do video care, such as using FaceTime or Zoom,” explained Liederman. “Before that, there was very little video care going on and telephone care was generally limited to follow-ups after scheduled visits or test results. With COVID, the use of telephone and video visits grew exponentially because we needed a way to continue to care for our patients in a safe and effective way.” You can read the full interview with Dr. Liederman here.

There is light on the horizon for moving forward in 2021. CNN reported that more than 9 million Americans have received their first dose of the coronavirus vaccine, yet more than 27 million doses have been distributed as of Jan. 13, according to the CDC. Also on Jan. 13, the Trump administration reversed course on its vaccine policy, and instructed states to begin vaccinating all Americans 65 and older, and release the second doses in reserve to make the vaccine more widely administered. While good in theory, this also runs the risk of depleting resources that are necessary for full vaccination. Both Pfizer/BioNTech and Moderna’s vaccines require two rounds of injection. COVID’s current toll at press time: 22,848,707 U.S. cases reported, 380,821 U.S. deaths.

It’s now time to apply lessons learned from 2020 in order to move forward into 2021.

Related Content

Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in t
55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned.

55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned.

News | Breast Imaging | February 24, 2021
Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations).
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Detroit-based magnetic resonance...
Findings indicate that PPC and GG are highly predictive of overall upstaging by PSMA PET/CT for patients with high-risk prostate cancer

Image courtesy of UCLA Health

News | PET-CT | February 23, 2021
February 23, 2021 — A...
Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in

Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in (a). The bottom row focuses on the detection of small calcifications, a key feature in DCIS. These are undetectable in (d), detected in (e), enhanced in the maximum intensity projection (MIP) image at the bottom of (f), and confirmed by histopathology in the top part of (f). The scale bar [shown in (b) and (e)] is the same for all images apart from (f), which has its own scale. Red arrows in (e) and (f) indicate the microcalcifications. Image courtesy of Professor Alessandro Olivo

News | Breast Imaging | February 22, 2021
February 22, 2021 — A new X-ray imaging scanne
Dr Sahar Saleem placing the mummy in the CT scanner

Dr. Sahar Saleem placing the mummy in the CT scanner. Image courtesy of Sahar Saleem

News | Computed Tomography (CT) | February 22, 2021
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an anci
Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | February 22, 2021
February 22, 2021 — According to an...
 Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a leading provider of healthcare analytics and cardiovascular information systems (CVIS). 
News | Enterprise Imaging | February 18, 2021
February 18, 2021 – Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired...
Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (a–c) are taken from a patient with a Pilocytic Astrocytoma, (d–f) are from a patient with an Ependymoma and (g–i) were acquired from a patient with a Medulloblastoma.

Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (ac) are taken from a patient with a Pilocytic Astrocytoma, (df) are from a patient with an Ependymoma and (gi) were acquired from a patient with a Medulloblastoma. Image courtesy of Nature Research Journal

News | Pediatric Imaging | February 17, 2021
February 17, 2021 — Diffusio...